Stock Report

Download full stock data and analysis for free Last Updated: 09-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Entero Health Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ENTERO | BSE: 544122

₹1,851.80

up-down-arrow ₹-46.60 (-2.45%)

As on 08-Sep-2026IST

Market cap

info icon

₹8,076 Cr

Revenue (TTM)

info icon

₹7,128 Cr

P/E Ratio

info icon

64.4

P/B Ratio

info icon

4.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1.60 38.23 31.94 25.93 29.93
EBIT 18.86 105.54 67.92 77.57 111.44
Net Profit 36.25 37.28 27.76 147.35 62.98
EPS 36.21 37.23 22.27 43.27 15.06
Book Value -- -- -2.20 62.84 16.24
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 2.791.953.733.382.76
Net Margin info 1.770.762.352.212.09
Return on equity info 6.684.017.588.576.40
Return on Capital info 9.046.67--10.939.16
Return on Assets info 3.721.455.324.684.29
Debt to Equity (x) info ----0.070.340.17

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
10.93
9.16
7.02
4.99
Peer Median
--
30.60
3.84
5.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

7.58

Higher than Peers by 6.05

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
7.58
8.57
6.40
5.08
--
Peer Median
1.53
29.06
5.08
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

5.32

Higher than Peers by 4.54

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
5.32
4.68
4.29
2.19
-0.91
Peer Median
0.78
14.98
2.19
1.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

3.73

Higher than Peers by 12.56

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
3.73
3.38
2.76
2.21
1.21
Peer Median
-8.83
--
2.93
3.78
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

2.35

Higher than Peers by 0.22

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
2.35
2.21
2.09
1.01
-0.34
Peer Median
2.12
8.35
1.96
3.27
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
2.87
2.71
1.65
0.40
Peer Median
--
--
0.00
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

31.94

Higher than Peers by 37.61

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
31.94
29.35
29.92
18.85
30.85
Peer Median
-5.67
--
50.75
56.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

67.92

Higher than Peers by 127.86

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
67.92
58.08
62.23
118.32
749.06
Peer Median
-59.94
--
75.04
59.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

27.76

Lower than Peers by 1.32

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
27.76
35.75
169.94
458.42
62.28
Peer Median
29.07
--
39.96
-8.68
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

22.27

Higher than Peers by 35.11

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
22.27
21.32
142.37
131.99
63.83
Peer Median
-12.85
--
-21.00
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
-2.19
5.11
2,485.71
-18.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.07

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
0.07
0.34
0.17
0.17
0.63
Peer Median
--
0.34
--
0.63
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
0.26
0.17
0.14
0.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.58

Lower than Peers by 12.49

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
1.58
1.58
2.46
3.34
1.64
Peer Median
14.07
2.15
2.47
2.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.05

Lower than Peers by 12.07

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
1.05
1.05
1.68
2.64
1.09
Peer Median
13.12
--
1.68
10.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

4.27

Lower than Peers by 3.35

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
4.27
4.30
4.33
1.54
0.92
Peer Median
7.62
4.70
2.66
2.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

17.01

Lower than Peers by 19.15

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
17.01
18.39
16.30
15.69
15.60
Peer Median
36.16
--
15.37
42.99
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

2.26

Higher than Peers by 2.07

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
2.26
2.11
2.03
2.16
2.71
Peer Median
0.19
--
1.51
1.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
56.56
51.78
52.59
49.19
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
41.57
38.71
35.49
36.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
34.66
24.83
22.51
21.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
63.47
65.66
65.57
64.15
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

64.40

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
64.40
47.12
52.15
109.53
--
Peer Median
--
16.74
65.30
159.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.66

Higher than Peers by 4.35

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
4.66
3.22
2.88
2.62
--
Peer Median
0.31
1.90
2.35
3.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

25.76

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
25.76
20.43
23.61
29.04
13.45
Peer Median
--
15.02
53.35
29.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

8,076

Higher than Peers by 8,042

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Entero Health
8,076
5,421
4,945
4,284
--
Peer Median
34
127
30
20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...